COPAXONE® (glatiramer acetate injection)

This information is only for patients who have been prescribed COPAXONE® (glatiramer acetate injection)

COPAXONE® is a medicine used for the treatment of relapsing forms of multiple sclerosis (MS). It modifies the way in which your body's immune system works and it is classified as a immunomodulating agent. The symptoms of MS are thought to be caused by a defect in the body's immune system. This produced patches of inflammation in the brain and spinal cord.

COPAXONE® is used to reduce the number of times you suffer attacks of MS (relapses). It has not been demonstrated to help if you have any form of MS which does not have relapses, or hardly any relapses. COPAXONE® may not have any effect on the length of time an MS attack lasts, or how badly you suffer during an attack.

For more information please refer to the Patient Information Leaflet.

COPAXONE® (glatiramer acetate injection) - CSYNC™ Autoinjector Training Guide Video

Understanding your Patient Information Leaflet

Within the original packaging of all regulated medicines, you will find an important document called the Patient Information Leaflet. We recommend you read this document carefully and keep it for future reference.

The Patient Information Leaflet gives you key information to help you get the desired results from your medicine. Reading the Patient Information Leaflet is designed to supplement – not replace – discussions with your doctor, pharmacist or other healthcare professional about the medication. 

If for any reason your medicine has not come with this leaflet, you can ask for one from your pharmacist. Patient Information Leaflets are also available to download from Teva’s product list.

Go to product list

Get in touch with Teva

We're here to assist patients and healthcare professionals with information about our medicines, devices and services.

Teva UK Medical Information

Our Medical Information Service can help with enquiries about Teva's medicines, devices and services.

Tel: 0207 540 7117 
Email: medinfo@tevauk.com

They can also provide copies of regulatory documents such as Patient Information Leaflets, or Summary of Product Characteristics. These documents are also available to download from Teva’s product list.

Go to product list

Reporting Suspected Side Effects

For patients taking a Teva medicine: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the Patient Information Leaflet. By reporting side effects you can help provide more information on the safety of a medicine.

Side effects can be reported to Teva:
Tel: 0207 540 7117
Email: 
uk.safety@tevauk.com
Online: Side Effect Reporting Form

You can also report side effects via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard

Life Effects™ - By patients, for patients

The only people who really know what you’re going through are other patients like you. Through Teva’s Life Effects™ website you can read stories, tips and real life experiences from other patients living with multiple sclerosis

Discover more Life Effects™ - By patients, for patients
Date of preparation: April 2022
Reference: COP-GB-NP-00009